Monocarboxylate transporter-1 (MCT1) protein expression in head and neck cancer affects clinical outcome
Abstract Treatment of locally advanced, unresectable head and neck squamous cell carcinoma (HNSCC) often yields only modest results with radiochemotherapy (RCT) as standard of care. Prognostic features related to outcome upon RCT might be highly valuable to improve treatment. Monocarboxylate transpo...
Guardado en:
Autores principales: | Martin Leu, J. Kitz, Y. Pilavakis, S. Hakroush, H. A. Wolff, M. Canis, S. Rieken, M. A. Schirmer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65dee9ff75eb467db2485a259080b37c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The neuroplastin adhesion molecules are accessory proteins that chaperone the monocarboxylate transporter MCT2 to the neuronal cell surface.
por: Marieangela C Wilson, et al.
Publicado: (2013) -
Cooperative transport mechanism of human monocarboxylate transporter 2
por: Bo Zhang, et al.
Publicado: (2020) -
Reduction of epileptiform activity in ketogenic mice: The role of monocarboxylate transporters
por: Linda S. Forero-Quintero, et al.
Publicado: (2017) -
Epithelial-to-Mesenchymal Transition-Derived Heterogeneity in Head and Neck Squamous Cell Carcinomas
por: Philipp Baumeister, et al.
Publicado: (2021) -
Regulation of monocarboxylic acid transporter-1 by cAMP dependent vesicular trafficking in brain microvascular endothelial cells.
por: Amy L Uhernik, et al.
Publicado: (2014)